Methoxy Polyethylene Glycol-Epoetin Beta Generics bulk supplier for pharma manufacturers

Methoxy Polyethylene Glycol-Epoetin Beta Generics 25–250 mcg Suppliers & Bulk Manufacturers

Available Forms: Solution for Injection

Available Strengths: 25–250 mcg

Reference Brands: Mircera® (US &EU)

Methoxy Polyethylene Glycol-Epoetin Beta, marketed as Mircera®, is a long-acting ESA used to treat anemia in CKD patients, both on and off dialysis. Approved in the EU and US, it is available as a solution for injection in prefilled syringes or vials, with extended dosing intervals (biweekly or monthly).

Get Enquiry / Request Bulk Quote

Quick Response Guaranteed | Verified Suppliers

Product Description:

Methoxy Polyethylene Glycol-Epoetin Beta, branded as Mircera®, is an advanced erythropoiesis-stimulating agent (ESA) designed for the treatment of anemia in chronic kidney disease (CKD) patients. Its long half-life enables once-monthly or biweekly dosing, improving compliance and reducing injection frequency. Approved in both the EU and US, Mircera® is widely used in dialysis and non-dialysis CKD populations. Available as prefilled syringes and vials in multiple strengths, it is an essential product in nephrology care. A strategic asset for pharmaceutical B2B partners, it offers opportunities in licensing, distribution, and hospital tenders across regulated markets with growing CKD treatment needs.

Methoxy Polyethylene Glycol-Epoetin Beta Generics — third party manufacturing & bulk supply

Methoxy Polyethylene Glycol-Epoetin Beta Generics 25–250 mcg is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:

Wholesale / bulk supply Stock or scheduled supply from an existing manufacturer. The fastest route where the product is already registered in your market.

Third party manufacturing Manufactured to your specification and packed under your own brand and label — suits distributors and brand owners building a portfolio in their market.

Dossier licensing Where a CTD, EU-CTD or ACTD dossier exists it can often be licensed for filing in your name, compressing market entry from years to months.

Indicative minimum order quantity

Methoxy Polyethylene Glycol-Epoetin Beta Generics is supplied as Solution for Injection — an injectable dosage form, so the indicative MOQ is 50,000 units. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.

Manufacturers of Methoxy Polyethylene Glycol-Epoetin Beta Generics listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding.

Request a quote for Methoxy Polyethylene Glycol-Epoetin Beta... →

Back to Listing

Frequently Asked Questions

Methoxy Polyethylene Glycol-Epoetin Beta Generics is listed as Solution for Injection in 25–250 mcg. Further strengths and pack presentations are confirmed with the manufacturer at RFQ stage.

Methoxy Polyethylene Glycol-Epoetin Beta Generics is referenced against Mircera® (US &EU). Reference brands are shown for identification only and remain the property of their respective trademark owners.